Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.78 |
| ▸ | MAPT | P10636 | 6/20 | 0.69 |
| ▸ | GAA | P10253 | 5/20 | 0.69 |
| ▸ | MEN1 | O00255 | 5/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.69 |
| ▸ | HPGD | P15428 | 4/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.69 |
| ▸ | SLC5A1 | P13866 | 2/20 | 0.69 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.69 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.69 |
| ▸ | CBS | P35520 | 1/20 | 0.61 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11566548 | 0.88 | LMNA (1.00) | LMNAMAPTGAAMEN1KMT2A | |
| SCHEMBL5036945 | 0.86 | MAPT (0.77) | LMNAMAPTGAAMEN1KMT2A | |
| SCHEMBL27697248 | 0.85 | MAPT (0.60) | LMNAMAPTGAAMEN1KMT2A | |
| SCHEMBL5034195 | 0.84 | LMNA (0.58) | LMNAMAPTGAAMEN1KMT2A | |
| SCHEMBL11628971 | 0.81 | SLC5A1 (0.71) | LMNAMAPTGAAMEN1KMT2A | |
| SCHEMBL455029 | 0.81 | SLC5A1 (1.00) | LMNAMAPTGAAMEN1KMT2A | |
| SCHEMBL11627675 | 0.81 | SLC5A1 (0.71) | LMNAMAPTGAAMEN1KMT2A | |
| SCHEMBL8575394 | 0.81 | MAPT (0.69) | LMNAMAPTGAAMEN1KMT2A | |
| SCHEMBL8578359 | 0.81 | MAPT (0.55) | LMNAMAPTGAAMEN1KMT2A | |
| SCHEMBL9123733 | 0.81 | LMNA (0.58) | LMNAMAPTGAAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116622664-A | Method for generating C-glycoside through biocatalysis | 湖南师范大学 | 2023-08-22 | — | — | CN | claimed |
| EP-2613819-B2 | LUBRICIOUS COATINGS FOR MEDICAL DEVICES | BIOINTERACTIONS LTD (GB) | 2020-11-25 | — | — | EP | claimed |
| EP-2613819-B1 | LUBRICIOUS COATINGS FOR MEDICAL DEVICES | BIOINTERACTIONS LTD (GB) | 2018-01-10 | — | — | EP | claimed |
| CN-103209717-B | Lubricious coatings for medical devices | BIOINTERACTIONS LTD | 2015-04-08 | — | — | CN | claimed |
| US-8541498-B2 | Lubricious coatings for medical devices | BIOINTERACTIONS LTD. (GB) | 2013-09-24 | — | — | US | claimed |
| EP-2613819-A1 | Lubricious coatings for medical devices | Biointeractions Ltd. (GB) | 2013-07-17 | — | — | EP | claimed |
| WO-2012032283-A1 | Lubricious coatings for medical devices | BIOINTERACTIONS LTD (GB) | 2012-03-15 | — | — | WO | claimed |
| US-20120059111-A1 | LUBRICIOUS COATINGS FOR MEDICAL DEVICES | BIOINTERACTIONS LTD. (GB) | 2012-03-08 | — | — | US | claimed |
| EP-0245518-A1 | ISOFLAVONE DERIVATIVES, SALTS THEREOF, AND ONCOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1987-11-19 | — | — | EP | claimed |
| US-20250084049-A1 | POLYCATIONIC SALTS OF PHENOLIC COMPOUNDS AND USES THEREOF | FIRMENICH INCORPORATED (US) | 2025-03-13 | — | — | US | disclosed |
| CN-119263971-A | Preparation method of cyclopentenone compound and salt thereof and application of cyclopentenone compound in treating cerebral apoplexy | 中国医学科学院药物研究所 | 2025-01-07 | — | — | CN | disclosed |
| CN-116622664-A | Method for generating C-glycoside through biocatalysis | 湖南师范大学 | 2023-08-22 | — | — | CN | disclosed |
| WO-2023278394-A1 | POLYCATIONIC SALTS OF PHENOLIC COMPOUNDS AND USES THEREOF | FIRMENICH INCORPORATED (US) | 2023-01-05 | — | — | WO | disclosed |
| US-11129781-B2 | Agent for hair deforming treatment | KAO CORPORATION (JP) | 2021-09-28 | — | — | US | disclosed |
| WO-1991016293-A1 | IMPROVED PROCESS FOR THE PREPARATION OF KETONE COMPOUNDS | CHINOIN GYÓGYSZER ÉS VEGYÉSZETI TERMÉKEK GYÁRA RT Tó utca 1-5 (HU) | 1991-10-31 | — | — | WO | disclosed |
| US-4960908-A | ANTIBODY INHIBITOR AND ANTICARCINOGENIC AGENT | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1990-10-02 | — | — | US | disclosed |
| US-4841077-A | Isoflavone derivatives, and salts thereof, and cancerocidal and immunosuppressive agents containing the same | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1989-06-20 | — | — | US | disclosed |
| EP-0245518-A1 | ISOFLAVONE DERIVATIVES, SALTS THEREOF, AND ONCOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1987-11-19 | — | — | EP | disclosed |
| US-4499171-A | IN ALKALI SOLUBLE NOVOLAK RESIN | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1985-02-12 | — | — | US | disclosed |
| EP-0092444-A2 | Positive type photosensitive resin composition | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1983-10-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250084049-A1 | POLYCATIONIC SALTS OF PHENOLIC COMPOUNDS AND USES THEREOF | PGC, SLC5A6, PUF60 | LMNA 3387/4885MAPT 3007/4885GAA 544/4885 |
| US-11129781-B2 | Agent for hair deforming treatment | GRHPR, SLC26A4, COL1A1 | LMNA 289/4885MAPT 1209/4885GAA 2213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.